Institut Regional DU Cancer DE Montpellier (ICM)
USPTO PatentsView assignee record - 16 granted patents across 7 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Institut ranks #17,785 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 7 technology areas.
- #17,785
- of 49,997 US assignees by volume
- 33rd percentile
- by Innovation Score (30.1/100)
- 12.7
- avg claims per patent
- +67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17785 · Foreign Corporation #17,785 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #17,785/49,997
- PHOTO-FINISH Ideal Warehouse…
- CPC-NARROW A61P · 7 areas
- INNOV-THIN 30.1/100
- CLAIMS-RICH 12.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ideal Warehouse Innovations Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Institut’s 30.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Institut
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Institut Regional… · this assignee 30
Institut Regional… · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Institut's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Institut?
Each dot is one of Institut’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Institut’s own 12.7 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Institut's grants concentrate
Institut Regional DU Cancer DE Montpellier (ICM) is a focused PatentsView assignee: 7 CPC subclasses with 68.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2017. By volume, Institut sits between INI Power Systems, Inc. and Ideal Warehouse Innovations Inc..
Institut's three-year grant acceleration
Institut Regional DU Cancer DE Montpellier (ICM) shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Institut's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- INI Power Systems
INI Power Systems, Inc.
16 patents
- Inis Biotech
Inis Biotech LLC
16 patents
- Inkbed
Inkbed, Inc.
16 patents
- Insectergy
Insectergy LLC
16 patents
- Intermetallics
Intermetallics Co., Ltd.
16 patents
- Intrinsic ID B V
Intrinsic ID B.V.
16 patents
- IP Liberty Vision
IP Liberty Vision Corporation
16 patents
- Ideal Warehouse I…
Ideal Warehouse Innovations Inc.
16 patents
- Institut Regional… ◀
Institut Regional DU Cancer DE Montpellier (ICM)
16 patents
What this shows Institut holds 16 patents at rank #17,775, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Institut
By rank, the assignees closest to #17,775 in granted patent volume.
- INI Power Systems, Inc. #17,771 · 16 patents
- Inis Biotech LLC #17,772 · 16 patents
- Inkbed, Inc. #17,773 · 16 patents
- Insectergy LLC #17,774 · 16 patents
- Intermetallics Co., Ltd. #17,776 · 16 patents
- Intrinsic ID B.V. #17,777 · 16 patents
- IP Liberty Vision Corporation #17,778 · 16 patents
- Ideal Warehouse Innovations Inc. #17,779 · 16 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Institut's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Institut's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 33rd percentile higher than 33% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 6.3% |
| 2018 | 3 | 18.8% |
| 2019 | 2 | 12.5% |
| 2020 | 3 | 18.8% |
| 2021 | 3 | 18.8% |
| 2022 | 1 | 6.3% |
| 2023 | 2 | 12.5% |
| 2024 | 1 | 6.3% |
Which technologies does Institut Regional DU Cancer DE Montpellier (ICM) patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Institut Regional DU Cancer DE Montpellier (ICM)'s patent record in context - here's where to go next.
- Institut Regional DU Cancer DE Montpellier (ICM)'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 68.8% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #17,785 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Institut Regional DU Cancer DE Montpellier (ICM) against INI Power Systems, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.